ACE and hydrops fetalis: Additionally, the PROVE-HF study demonstrated that ARNI may also aid in ventricular remodeling in HF patients, as evidenced by significant increases in LVEF and reductions in LVEDV and LVESV indexes at the 12-month mark, even in patients who had already been exposed to ACE inhibitors or ARB [209,210].